AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

According to a recent survey commissioned by the Austrian Lung Union (ÖLU), more than half of asthma patients with nasal polyps do not receive targeted treatment.

CHENNAI: It’s surprising how many of us struggle with breathing — even though it is the most natural thing to do. But ...

Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is an inflammatory condition characterized by persistent ... The final draft of the survey underwent rigorous revision by the authors, ...

GSK plc (LSE/NYSE: GSK) today announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, ...

GSK plc announced that the China National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with ...

It is estimated that about 107 million people in China suffer from chronic sinusitis, about 1/3 of whom have chronic sinusitis with nasal polyps. People with CRSwNP experience symptoms such as nasal ...

According to a recent study by Future Market Insights, the global market for fragmentable nasal and ear dressings is poised ...

Nasal sprays can treat congestion and other symptoms of seasonal allergies or a cold. They work by delivering a fine mist of medication into your nostrils. Since the lining of your nose is rich with ...

Many patients with chronic sinusitis will have nasal exams that are not diagnostic ... In our clinic, an ENT exam chair with a headrest is used and the rhinolaryngoscope is attached to a video ...

Irrigate the nasal sinuses with saline solution. Use a humidifier or vaporizer to keep the air ... If you continue to have problems, see an ear, nose, and throat specialist (ENT) to have the wax ...